Taylor Morrison Home TMHC · NYSE
$72.45 -0.03% (-$0.02)
Summary
66 / 100 · Bulios Score
What speaks for it
- You pay 8.5 USD for 1 USD of yearly profit, little for its sector.
- It bought back its own shares for $381.0M in the last fiscal year, 5.7% of its market value.
What to watch
- Earnings per share fell by 5.0% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 8.5 USD for 1 USD of yearly profit. Over the last five years it was 6.5 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 5.8% a year over 5 years. Over the last 3 years it fell by 0.4% a year. Earnings per share fell by 5.0% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 14
- Hold 16
- Sell 1
No analyst has published a price target.
45% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
This revenue breakdown is on the way.
By region
This revenue breakdown is on the way.